Antimicrobial prescribing in European nursing homes

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 7, 2011, Pages 1609-1616

  McClean, Pamela ^a   Hughes, Carmel ^a   Tunney, Michael ^a   Goossens, Herman ^b   Jans, Beatrice ^c  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

Antibiotics; ESAC; Long term care

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIMYCOBACTERIAL AGENT; BENZATHINE PENICILLIN V; CIPROFLOXACIN; METHENAMINE; NITROFURANTOIN; PENICILLIN V; PIVMECILLINAM; PSEUDOMONIC ACID; TRIMETHOPRIM;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; EUROPE; FEMALE; HUMAN; INFECTION CONTROL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NURSING HOME; NURSING HOME PATIENT; PRESCRIPTION;

ANTI-BACTERIAL AGENTS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; EUROPE; HUMANS; NURSING HOMES;

EID: 79958865823     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr183     Document Type: Article

References (37)

1. Goossens H, Ferech M, Vander Stichele R et al. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365: 579-87.
2. Arias C, Murray B. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge. N Engl J Med 2009; 360: 439-43.
3. Christensen K, Doblhammer G, Rau R et al. Ageing populations: the challenges ahead. Lancet 2009; 374: 1196-208.
4. European Commission. Long-term Care in the European Union. 2008. http://ec.europa.eu/employment_social/spsi/docs/social_protection/2008/hc_Itc_en.pdf (11 April 2011, date last accessed).
5. Yoshikawa T. Epidemiology and unique aspects of aging and infectious diseases. Clin Infect Dis 2000; 30: 931-3.
6. Smith P, Rusnak P. Infection prevention and control in the long-term-care facility. Infect Control Hosp Epidemiol 1997; 18: 831-49.
7. Gavazzi G, Krause K. Ageing and infection. Lancet Infect Dis 2002; 2: 659-66.
8. Stone S, Kibbler C, Bowman C et al. Controlling infection in British nursing homes. BMJ 2001; 322: 506.
9. Loeb M, Craven S, McGeer A et al. Risk factors for resistance to antimicrobial agents among nursing home residents. Am J Epidemiol 2003; 157: 40-7.
10. Vander Stichele R, Elseviers M, Ferech M et al. Hospital consumption of antibiotics in 15 European countries: results of the ESAC retrospective data collection (1997-2002). J Antimicrob Chemother 2006; 58: 159-67.
11. Zarb P, Amadeo B, Muller A et al. Identification of targets for quality improvement in antimicrobial prescribing: the Web-based ESAC point prevalence survey 2009. J Antimicrob Chemother 2011; 66: 443-9.
12. Van De Sande-Bruinsma N, Grundmann H, Verloo D. Antimicrobial drug use and resistance in Europe. Emerg Infect Dis 2008; 14: 1722-30.
13. Blix H, Bergman J, Schjøtt J. How are antibacterials used in nursing homes? Results from a point-prevalence prescription study in 44 Norwegian nursing homes. Pharmacoepid Drug Saf 2010; 10: 1025-30.
14. Petterson E, Vernby A, Molstad S et al. Infections and antibiotic prescribing in Swedish nursing homes: a cross-sectional study. Scand J Infect Dis 2008; 40: 393-8.
15. Benoit S, Nsa W, Richards C et al. Factors associated with antimicrobial use in nursing homes: a multilevel model. J Am Geriatr Soc 2008; 56: 2039-44.
16. Improving Patient Safety in Europe (IPSE) 2008. Work Package 7 D72: Proposal-Surveillance of Nursing Home Acquired Infections in Europe. http://ecdc.europa.eu/ipse/Working%20packages/Working%20Package%207.htm (11 April 2011, date last accessed).
17. WHO. The ATC/DDD System. 2010. www.whocc.no/atc_ddd_index (11 April 2011, date last accessed).
18. Loeb M, Simor A, Landry L et al. Antibiotic use in Ontario facilities that provide chronic care. J Gen Intern Med 2001; 16: 376-83.
19. Rotjanapan P, Dosa D, Thomas K. Potentially inappropriate treatment of urinary tract infections in two Rhode Island nursing homes. Arch Intern Med 2011; 171: 438-43.
20. Wojkowska-Mach J, Gryglewska B, Romanisyn D et al. Point prevalence study of infections and use of antibiotics in Polish long-term-care facility. In: Abstracts of the Fifth Decennial International Conference on Healthcare-Associated Infections, 2010. Abstract 476. Society for Healthcare Epidemiology of America (SHEA), Arlington, VA, USA.
21. Blix H, Roed J, Sti M. Large variation in antibacterial use among Norwegian nursing homes. Scand J Infect Dis 2007; 39: 536-41.
22. Ferech M, Coenen S, Malhotra-Kumar S et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother 2006; 58: 401-7.
23. Elseviers M, Ferech M, Vander Stichele R et al. Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations. Pharmacoepidem Drug Saf 2007; 16: 115-23.
24. Lee B, Simpson J, Craig J et al. Methenamine hippurate for preventing urinary tract infections. Cochrane Database Syst Rev 2007; issue 4: CD003265.
25. Cooke F, Holmes A. The missing care bundle: antibiotic prescribing in hospitals. Int J Antimicrob Agents 2007; 30: 25-9.
26. Dellit T, Owens R, McGowan J et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007; 44: 159-77.
27. Takahashi P, Trang N, Chutka D et al. Antibiotic prescribing and outcomes following treatment of symptomatic urinary tract infections in older women. J Am Med Dir Assoc 2004; 5 Suppl: S11-5.
28. Kuijper E, Coignard B, Tüll P et al. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006; 12: 2-18.
29. Crogan N, Evans B. Clostridium difficile: an emerging epidemic in nursing homes. Geriatr Nurs 2007; 28: 161-4.
30. Baldwin N, Gilpin D, Hughes C et al. Prevalence of methicillin-resistant Staphylococcus aureus colonization in residents and staff in nursing homes in Northern Ireland. J Am Geriatr Soc 2009; 57: 620-6.
31. Denis O, Jans B, Deplano A et al. Epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) among residents of nursing homes in Belgium. J Antimicrob Chemother 2009; 64: 1299-306.
32. Rooney P, O'Leary M, Loughrey A et al. Nursing homes as a reservoir of extended-spectrum b-lactamase (ESBL)-producing ciprofloxacinresistant Escherichia coli. J Antimicrob Chemother 2009; 64: 635-41.
33. Schweizer A, Hughes C, Macauley D et al. Managing urinary tract infections in nursing homes: a qualitative assessment. Pharm World Sci 2005; 27: 159-65.
34. Gross P, Pujat D. Implementing practice guidelines for appropriate antimicrobial usage: a systematic review. Med Care 2001; 39: 1155-69.
35. Naughton B, Mylotte J, Ramadan F et al. Antibiotic use, hospital admissions and mortality before and after implementing guidelines for nursing home acquired pneumonia. J Am Geriatr Soc 2001; 49: 1020-4.
36. Arnold S, Straus S. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev 2005; issue 4: CD003539.
37. Davey P, Brown E, Fenelon L et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2005; issue 4: CD003543.